Bayer submits Xarelto MAA

Bayer (FSE:BAY; BAY) submitted an MAA to EMEA for Xarelto rivaroxaban to prevent venous thromboembolism (VTE) after major orthopedic surgery of the lower limbs. Johnson & Johnson (JNJ) has U.S. rights...